Lecturio’s integrated cardiovascular pathology course held by MD Carlo Raj will not only equip you with knowledge about the most important diseases related to the cardiovascular system, but will also build bridges to the related medical sciences, and thus provide you with the deepest understanding of all cardiovascular pathology topics. We are convinced that learning cardiovascular pathology has never been so inspirational, comprehensive and fun.
Upon completion of this course you will be able to easily answer all pathology questions regarding cardiovascular diseases. This is very important because cardiovascular pathology is one of the central topics in the USMLE Step 1 exam.
The course will cover the following high yield topics, among others:
Before taking this course, you should already have a strong foundation in the basic sciences such as anatomy, physiology, biochemistry, microbiology & immunology, and pharmacology. MD Carlo Raj will not only familiarize you with the concepts but, in doing so, will support you in building a long-term understanding of cardiovascular pathology. As a result, you will master the boards and become a better physician.
Need to further explore surgical and percutaneous treatment options incl valvuloplasty and in which patients valve replacement vs valvuloplasty is preferred
This was a well explained lecture but a trend I have noticed with these videos so far is the immense focus on physiology at the expense of diagnosis and management which is important for step 2. The avoidance of vasodilators, ACE-Inhibitors etc was glossed over. Moreover, a discussion of surgical options including valvuloplasty and percutaneous valve replacement was omitted. Common on guys if you are serious about step-2 and want people to transition from established providers like Kaplan then you need to focus more on management. I'm beginning to lose faith in these videos
Really good talk but would have been great to discuss the choice between rate and rhythm controlled Rx as well as a section devoided to AVNRT and AVRT. I'm still a bit confused about why the management differs between these two supraventricluar tachy and WPW
The lecture on management was extremely superficial and not suitable for board exams. No mention of: Newer agents such as ticagrelor/prasugrel When you would choose PCI vs thrombolysis risk stratification of NSTEMI patients with the TIMI score and subsequent angio When you would use CABG first line This talk I feel is more step 1 then step 2. Step 2 needs to focus more on decision making rather than lengthy talk on the basic pathophys I had to go back to references to Toronoto Notes to fill this gap